戻る
化工社化工社 化学情報印刷レポート · 研究参考用
HCID 23666110作成日:2026年10月23日

Liothyronine Sodium

https://huagongshe.com/ja/chemical/23666110

Liothyronine Sodium の分子構造式

識別子と物理属性

CAS No.55-06-1
分子式C15H11I3NNaO4
平均分子量672.95 g/mol
単同位体質量672.77199611 g/mol
SMILESN[C@@H](Cc1cc(I)c(Oc2ccc(O)c(I)c2)c(I)c1)C(=O)[O-].[Na+]
InChIKeySBXXSUDPJJJJLC-YDALLXLXSA-M
PubChem CID23666110
ChEMBLCHEMBL1201119
ChEBICHEBI:6484
EC No.200-223-5
DTXSIDDTXSID8047505

化学・物理的性質

極性表面積95.6
水素結合供与体数2
水素結合受容体数5
回転可能結合数5
重原子数24
形式電荷0
複雑度408
Human DrugsFDA approved drugs -> Active ingredient
Animal DrugsActive Ingredients (Liothyronine Sodium) -> FDA Greenbook
Collision Cross Section205.2 Ų [M+H]+ [CCS Type: TWMethod: calibrated with polyalanine and drug standards]

安全性と法規制

GHS 分類This chemical does not meet GHS hazard criteria for 40% (2 of 5) of reports.WarningH302 (40%): Harmful if swallowed [Warning Acute toxicity, oral]P260, P261, P264, P264+P265, P270, P271, P280, P301+P317, P302+P352, P304+P340, P305+P351+P338, P317, P319, P321, P330, P337+P317, P362+P364, and P501 (click each P-code to see the statement)Aggregated GHS information provided per 5 reports by companies from 4 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.
その他の安全情報IMAP assessments - L-Tyrosine, O-(4-hydroxy-3-iodophenyl)-3,5-diiodo-, monosodium salt: Environment tier I assessment
Hazard Classes and CategoriesAcute Tox. 4 (40%)
暴露経路95% in 4 hours
毒性の概要The hormones, T<sub>4</sub> and T<sub>3</sub>, are tyrosine-based hormones produced by the thyroid gland. Iodine is an important component in their synthesis. The major form of thyroid hormone in the blood is thyroxine (T<sub>4</sub>). This is converted to the more active liothyronine form by deiodinases in peripheral tissues. Liothyronine acts on the body to increase the basal metabolic rate, affect protein synthesis and increase the body's sensitivity to catecholamines (such as adrenaline). The thyroid hormones are essential to proper development and differentiation of all cells of the human body. To various extents T<sub>4</sub> and T<sub>3</sub> regulate protein, fat and carbohydrate metabolism. Their most pronounced effect is on how human cells use energetic compounds. The thyroid hormone derivatives bind to the thyroid hormone receptors initially to initiate their downstream effects.
Carcinogen ClassificationNo indication of carcinogenicity to humans (not listed by IARC).
Drug Induced Liver InjuryDrug Induced Liver Injury Rank (DILIrank 2.0)Liothyronine sodiumvNo-DILI-concernNo matchDOI:10.1016/j.drudis.2016.02.015
Liothyronine Sodium|化工社